alexa Depression & Alcoholism As Co-morbidities
ISSN: 2167-1044

Journal of Depression and Anxiety
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference on Depression, Anxiety and Stress Management
June 21-22, 2017 London, UK

Wayne Grant Carter
University of Nottingham, UK
ScientificTracks Abstracts: J Depress Anxiety
DOI: 10.4172/2167-1044-C1-002
The brain is a target of physiological stress, and is influenced and responds to stress-induced adaptation via synaptic plasticity. This brain structural remodelling can influence an individual’s behaviour and physiological responses. Dysregulation of stress may contribute to the development of a number of psychiatric disorders, including major depressive disorder (MDD). The management of stress typically involves pharmacological and non-pharmacological interventions. For the former, drug or herb therapy has been employed, but stressed individuals may also adopt acute (binge) and/or repetitive alcohol drinking behaviour. Excessive alcohol intake also drives neurobiological changes, some of which may contribute to the development of MDD. Alcohol dependency and MDD have alarmingly high rates of co-morbidity, indicative of a commonality of molecular mechanisms. In this talk I will highlight some of the neurobiological changes associated with stress, alcoholism and consider alcoholism and depression co-morbidity.

Wayne Grant Carter completed a BSc (Hons) degree in Biochemistry with Nutrition and then a PhD in Biochemistry at the University of Southampton. He subsequently undertook post-doctoral research posts at The Babraham Institute, Cambridge; Imperial College, London; University of California at Irvine, USA, and the University of Oxford. Additionally, he has worked for a global reagent supplier, Sigma, a SME company, Mobious Genomics, and has been employed as a consultant for Syngenta. He is currently a Lecturer and research Group Leader within the School of Medicine, University of Nottingham. His research interests are varied and include detection and utilisation of novel biomarkers of toxicological exposure. He currently serves on the Editorial Board of over 40 different medicallyrelated journals and reviews for over 50 more.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version